Table 4.
Comparison for risk factors associated with medication and dialysis modality
| Variables | Nonsurvivor (n = 451) | Survivor (n = 2,241) | P |
|---|---|---|---|
| Hemodialysis (h/wk) | 8.4±5.4 | 9.4±3.7 | <0.001 |
| In-hospital medication | |||
| Loop diuretics | 381 (84.5) | 1,374 (61.3) | <0.001 |
| Inotropics | 394 (87.4) | 860 (38.4) | <0.001 |
| ACEI | 62 (13.7) | 456 (20.3) | <0.001 |
| ARB | 97 (21.5) | 1,040 (46.4) | <0.001 |
| Statin | 31 (6.9) | 449 (20.0) | <0.001 |
| CCB | 166 (36.8) | 1,328 (59.3) | <0.001 |
| Vancomycin | 176 (39) | 296 (13.2) | <0.001 |
| Steroid | 123 (27.3) | 290 (12.9) | <0.001 |
| Anticoagulation | 145 (32.2) | 1,142 (51.0) | <0.001 |
| ICU care | 354 (78.5) | 433 (19.3) | <0.001 |
| ICU duration (d) | 18.1±26.0 | 13.4±16.2 | 0.003 |
| CRRT | 110 (24.4) | 75 (3.3) | <0.001 |
| CRRT duration (d) | 10 (2.2) | 56 (2.5) | 0.541 |
| Ventilator | 310 (68.7) | 216 (9.6) | <0.001 |
| Access | |||
| Femoral venous | 289 (64.1) | 644 (28.8) | <0.001 |
| Temporary jugular venous | 43 (9.5) | 243 (10.8) | 0.451 |
| Jugular venous, tunneled cuffed jugular catheter | 77 (17.1) | 576 (25.7) | <0.001 |
| Arteriovenous fistula or graft | 42 (9.3) | 778 (34.7) | <0.001 |
Data are presented as mean ± SD or n (%).
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; CRRT, continuous renal replacement therapy; ICU, intensive care unit.